Vice Health and Wellness Inc.
VICE
CNSX
| Weiss Ratings | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 160.16K | |||
| Enterprise Value | -32.69K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 39.61M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 1066 West Hastings Street Vancouver, BC V6E 3X1 | |||
| Website | vice.health | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -805.19% | |||
| Profit Margin | -716.51% | |||
| Management Effectiveness | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -126.65% | |||
| Return on Equity | -- | |||
| Income Statement | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 98.10K | |||
| Total Revenue (TTM) | 98.10K | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -21.20K | |||
| EBITDA (TTM) | -527.50K | |||
| EBIT (TTM) | -789.90K | |||
| Net Income (TTM) | -702.90K | |||
| Net Income Avl. to Common (TTM) | -702.90K | |||
| Total Revenue Growth (Q YOY) | 10.42% | |||
| Earnings Growth (Q YOY) | 73.03% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 91.96% | |||
| Balance Sheet | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 93.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 215.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 78.30K | |||
| Current Ratio (Q) | 1.569 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 215.90K | |||
| Total Current Liabilities (Q) | 137.60K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 137.60K | |||
| Total Common Equity (Q) | 183.50K | |||
| Cash Flow | VICE - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 83.90K | |||
| Net Change in Cash (TTM) | -203.90K | |||
| Levered Free Cash Flow (TTM) | -176.50K | |||
| Cash from Operations (TTM) | -317.40K | |||
